Viatris (VTRS) Net Margin (2019 - 2026)

Viatris' (VTRS) quarterly Net Margin came in at 5.03% in Q1 2026, up 9850.0% year-on-year from 0.05% in Q1 2025, and up 155.27% quarter-over-quarter from 9.09% in Q4 2025.

Viatris (VTRS) Net Margin (2019 - 2026) Analysis & Trends

Viatris' Net Margin history runs 8 years deep, the most recent figure standing at 5.03% for Q1 2026.

  • On a quarterly basis, Net Margin rose 9850.0% year-over-year to 5.03% in Q1 2026; TTM through Mar 2026 was 2.03%, a 2452.0% increase from a year earlier, with the FY2025 full-year figure at 24.58%, down 2026.0% from the prior year.
  • Net Margin rose to 5.03% in Q1 2026 per VTRS's latest filing, from 9.09% in the prior quarter.
  • Across five years, Net Margin topped out at 25.85% in Q4 2022 and bottomed at 93.48% in Q1 2025.
  • The 5-year median for Net Margin is 3.11% (2024), against an average of 3.89%.
  • Across the five-year window, Net Margin tumbled 9659 bps in 2025 and soared 9850 bps in 2026, its largest moves.
  • Year by year, Net Margin stood at 25.85% in 2022, then tumbled by 178 bps to 20.15% in 2023, then climbed by 26 bps to 14.84% in 2024, then surged by 39 bps to 9.09% in 2025, then surged by 155 bps to 5.03% in 2026.
  • Per Business Quant, the three latest VTRS Net Margin figures stand at 5.03% (Q1 2026), 9.09% (Q4 2025), and 3.41% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -21.19%

Historic Data

Download Data
DateValue
Mar 31, 2026 5.03%
Dec 31, 2025 -9.09%
Sep 30, 2025 -3.41%
Jun 30, 2025 -0.13%
Mar 31, 2025 -93.48%
Dec 31, 2024 -14.84%
Sep 30, 2024 2.53%
Jun 30, 2024 -8.62%
Mar 31, 2024 3.11%
Dec 31, 2023 -20.15%
Sep 30, 2023 8.43%
Jun 30, 2023 6.74%
Mar 31, 2023 6.03%
Dec 31, 2022 25.85%
Sep 30, 2022 8.71%
Jun 30, 2022 7.65%
Mar 31, 2022 9.55%
Dec 31, 2021 -5.99%
Sep 30, 2021 6.89%
Jun 30, 2021 -6.12%